<?xml version="1.0" encoding="UTF-8"?>
<p>The aim of this study was to therefore describe clinical patient data, viral replication capacity, and host innate immune modulation of two newly detected ORF6 deletion variants detected in early April from routine genomic surveillance of COVID-19 patients in Lyon, France.</p>
